Ben Lehner leads Generative and Synthetic Genomics at the Wellcome Sanger Institute and contributes to Systems and Synthetic Biology at CRG Genomics. He co-founded the Barcelona Collaboratorium, demonstrating leadership in collaborative scientific innovation. Based in Barcelona and Cambridge, Lehner specializes in genomics and synthetic biology, driving advances in these fields through research and entrepreneurship.

‌